Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Eisai Co stock price, quote, forecast and news

4523.T
JP3160400002
855526

Price

5,800.00
Today +/-
+0.52
Today %
+1.42 %
P

Eisai Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Eisai Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Eisai Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Eisai Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Eisai Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Eisai Co Stock Price History

DateEisai Co Price
9/11/20245,800.00 undefined
9/10/20245,718.00 undefined
9/9/20245,724.00 undefined
9/6/20245,809.00 undefined
9/5/20245,868.00 undefined
9/4/20245,989.00 undefined
9/3/20246,067.00 undefined
9/2/20246,022.00 undefined
8/30/20246,119.00 undefined
8/29/20246,113.00 undefined
8/28/20246,118.00 undefined
8/27/20246,053.00 undefined
8/26/20246,024.00 undefined
8/23/20246,167.00 undefined
8/22/20246,183.00 undefined
8/21/20245,937.00 undefined
8/20/20245,910.00 undefined
8/19/20245,878.00 undefined
8/16/20246,000.00 undefined
8/15/20245,834.00 undefined

Eisai Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Eisai Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Eisai Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Eisai Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Eisai Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Eisai Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Eisai Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Eisai Co’s growth potential.

Eisai Co Revenue, EBIT and net profit per share

DateEisai Co RevenueEisai Co EBITEisai Co Net Income
2027e906.89 B undefined89.69 B undefined74 B undefined
2026e853.47 B undefined71.48 B undefined60.52 B undefined
2025e774.31 B undefined60.1 B undefined45 B undefined
2024741.75 B undefined46.48 B undefined42.41 B undefined
2023744.4 B undefined40.44 B undefined55.43 B undefined
2022756.23 B undefined53.86 B undefined47.95 B undefined
2021645.94 B undefined53.02 B undefined41.94 B undefined
2020695.62 B undefined136.23 B undefined121.77 B undefined
2019642.83 B undefined93.32 B undefined63.39 B undefined
2018600.05 B undefined76.18 B undefined51.85 B undefined
2017539.1 B undefined60.81 B undefined39.36 B undefined
2016547.92 B undefined55.27 B undefined54.93 B undefined
2015548.47 B undefined28.6 B undefined43.25 B undefined
2014600.36 B undefined71.11 B undefined32.96 B undefined
2013573.66 B undefined70.46 B undefined48.28 B undefined
2012647.98 B undefined95.75 B undefined58.51 B undefined
2011768.91 B undefined113.12 B undefined67.39 B undefined
2010803.15 B undefined86.41 B undefined40.34 B undefined
2009781.74 B undefined91.81 B undefined47.68 B undefined
2008734.29 B undefined17.76 B undefined-17.01 B undefined
2007674.11 B undefined105.27 B undefined70.61 B undefined
2006601.25 B undefined95.16 B undefined63.41 B undefined
2005533.01 B undefined86.4 B undefined55.51 B undefined

Eisai Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
236.27258.35273.4281.56301.76284.86302.47361.71431.67466.61500.16533.01601.25674.11734.29781.74803.15768.91647.98573.66600.36548.47547.92539.1600.05642.83695.62645.94756.23744.4741.75774.31853.47906.89
-9.345.832.987.17-5.606.1819.5919.348.097.196.5712.8012.128.936.462.74-4.26-15.73-11.474.66-8.64-0.10-1.6111.317.138.21-7.1417.07-1.56-0.364.3910.226.26
66.3964.4465.5066.2268.9269.3869.6972.7476.4778.0480.5781.4382.5483.7883.8080.5079.9978.1873.2569.6568.6664.7064.6063.7366.4871.3475.9175.0478.1076.1279.06---
156.87166.49179.09186.44207.97197.64210.79263.11330.1364.15402.98434.05496.25564.74615.35629.33642.42601.14474.62399.55412.21354.87353.97343.57398.89458.59528.07484.69590.62566.63586.42000
33.7739.2342.8343.7641.5738.6437.165972.7575.6782.8686.495.16105.2717.7691.8186.41113.1295.7570.4671.1128.655.2760.8176.1893.32136.2353.0253.8640.4446.4860.171.4889.69
14.2915.1915.6715.5413.7713.5612.2916.3116.8516.2216.5716.2115.8315.622.4211.7410.7614.7114.7812.2811.845.2110.0911.2812.7014.5219.588.217.125.436.277.768.389.89
15.117.3919.0719.4519.815.8811.2823.3336.5240.9650.1155.5163.4170.61-17.0147.6840.3467.3958.5148.2832.9643.2554.9339.3651.8563.39121.7741.9447.9555.4342.414560.5274
-15.129.711.971.81-19.80-28.96106.7856.5512.1622.3510.7614.2411.36-124.09-380.26-15.3967.07-13.18-17.49-31.7331.2527.00-28.3531.7322.2692.10-65.5614.3315.59-23.506.1134.5122.26
----------------------------------
----------------------------------
257257273291295299299299299293291287286285284285285285285285285285.75286.47286.42286.48286.66286.65286.71286.73286.76286.8000
----------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Eisai Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Eisai Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (B)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (T)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (B)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (T)
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                             
119.02132.76189.94182.83141.35152.66148.4126.53131.49136.6154.89147.05194.18180.05124.88152.08153.46181.66188.18187.46174.84201.76196.37229.65289.19293.98255.8249.01310.07267.89305.12
90.2997.03102.03104.01115.51111.13106.88115.89129.56148.85131.85141.74148.39161.82171.84191.3206.98195.15197185.37173.89164.62138.53142.52142.89137.34170.06147.39194.05161.16168.84
0000000000000000000009.729.1411.988.5819.319.9612.9213.926.0948.37
22.8224.8927.4631.7530.2231.5433.9933.7233.6235.0635.1139.4744.9552.7658.0964.5267.5570.8175.287.6288.1287.6473.6882.8880.9367.8965.7485.1299.01140.42174.65
3.013.63.096.476.585.2723.1530.0525.7528.4732.3337.3345.0846.5860.7656.8852.0561.7565.4670.2866.5710.9930.0917.1314.3143.1719.8523.9123.5826.6426
235.15258.28322.51325.07293.66300.6312.42306.19320.43348.98354.19365.58432.6441.21415.57464.77480.04509.36525.84530.73503.42474.72447.8484.16535.91561.68521.41518.34640.61622.2722.98
65.1876.1684.8695.25116.31113.92109.54106.72112.11111.68116.69122.92128.68133.84147.08155.5156.64149.13143.58142.25131.44133104.56103.57103.06105.17144.64160.93169.93166.63164.89
33.5824.155.8964.645.625.7177.2465.4766.9982.4389.3105.45111.8689.5460.5864.854.5639.0834.2933.2742.3443.8254.4647.7953.0139.7843.8244.0352.4657.67
1.460.930.670.480.390.250.190.150.110.10.060.110.060.020.010000000000000000
0.340.520.440.490.330.598.048.9514.4916.0415.0637.0143.2116.674.7770.0463.4256.7254.2557.2756.58127.63104.16112.5107.4498.14106.09106.4295.4589.2385.49
0.1600000000000045.99342.92314.18262.47211.49184.39178.77178.24183.76174.88173.97164.96172.16168.68171.78191.76208.82236.37
24.8229.2128.5729.3437.742.449.7850.1944.9947.9347.3647.7837.2342.654.0483.0874.5465.0357.5346.9442.5592.3798.77102.1189.8881.3781.5487.1397.54124.01126.39
125.54130.96120.43131.55159.39162.78173.25243.25237.17242.74261.58297.13314.63350.9708.37683.38621.86536.93478.82459.52442.08579.09526.19546.61513.13509.84540.74570.08598.71641.15670.82
0.360.390.440.460.450.460.490.550.560.590.620.660.750.791.121.151.11.0510.990.951.050.971.031.051.071.061.091.241.261.39
                                                             
23.5223.5223.5429.6344.8544.8544.8944.8944.8944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.9944.99
33.7933.7933.839.8955.0955.0955.1255.1255.1355.2255.2255.2255.2255.2256.9756.9556.9356.9156.956.8656.9658.0458.2377.6577.5677.5977.6177.6377.6178.8178.86
137.91154.64170.1184.9199.29208.67229.41246.35275.05302.67342.83387.08429.03469.93416.52423.92424.5449.28465.17470.8460.99387.97394.97394.98414.97438.49505.36506.4506.58522.77526.49
0000000-1.461.47-1.5-6.27-4.911.574.98-38.87-58.73-75.05-106.71-111.09-67.5-29.68145.06111.7102.991.34101.7384.51106.63153.58187.02258.89
00000001.01-0.121.428.689.3720.3319.869.511.134.880.071.244.3413.210000000000
195.22211.95227.44254.42299.23308.61329.42345.91376.41402.8445.45491.75551.13594.98489.11468.25456.25444.54457.21509.48546.46636.06609.89620.52628.85662.79712.47735.65782.76833.6909.23
15.061613.6114.6313.4714.1314.1913.9216.5816.1315.8615.6624.4119.2718.3119.120.312226.2126.0526.927.7727.334.5836.3831.2531.0128.329.6333.9523.96
23.9521.6623.0921.8227.5526.7822.523.4425.522.628.6433.7242.651.4356.7454.5759.6658.8156.024754.170000000000
18.1224.0826.1926.6825.0329.8941.1398.7397.63107.1390.2899.34110.73120.84105.17145.93115.16104.379.7166.2861.51151.06123.19139.11188.89215.49185.96187.73283.7223.79255.88
2.474.633.87.418.186.467.497.51.050.040.190.830.410.24362.822224067.66.210.240011.4900031.224.63
0.060.3714.3550.151.5210.0511.5510.165.480.100000.1501.11404068.8145.29304.2250539.9934.9939.990100
59.6666.7481.03120.6975.7487.3196.86153.75146.25145.99134.97149.55178.15191.78543.19241.6220.24225.11207.93215.74194.09209.07154.71223.69241.67295.74251.97256.02313.33298.95304.47
68.5470.4194.7241.2937.8127.3215.715.850.10000050.83399.7387.19339.88299.31237.62195.87205.85203.59163.47156.7489.9154.9549.9194.8984.9134.77
0000001.110.840.870.340.320.10.090.140.2527.6823.7924.823.0219.6417.510.510.290.450.50.280.570.510.480.660.7
29.3831.6231.2631.6231.7931.9433.0933.9739.1547.852.4244.4740.4737.5435.8846.1348.9546.1250.9742.9527.0936.3338.5740.5636.0333.6252.0355.6359.0756.2754.88
97.92102.03125.9772.9169.659.2649.9140.6540.1148.1552.7444.5640.5637.63126.95473.51459.92410.8373.3300.21240.47242.69242.45204.48193.26123.8107.55106.05154.45141.83190.35
157.58168.77207193.6145.34146.56146.77194.4186.36194.14187.71194.12218.71229.41670.14715.11680.16635.92581.23515.95434.56451.76397.16428.17434.93419.54359.51362.07467.78440.78494.82
0.350.380.430.450.440.460.480.540.560.60.630.690.770.821.161.181.141.081.041.030.981.091.011.051.061.081.071.11.251.271.4
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Eisai Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Eisai Co's financial health and stability.

Assets

Eisai Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Eisai Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Eisai Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Eisai Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (B)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
25.5442.8462.7569.8382.5287.6596.08110.3317.6570.4874.28102.5794.6571.4358.2125.8850.4757.6776.889.45128.0652.354.4645.01
15.1214.9815.2717.918.4222.3624.9926.834.458.6357.3751.2648.6951.0948.5238.9434.0626.4826.1826.8433.735.7738.439.98
000000000000000000000000
-27.43-6.85-46.32-59.28-27.38-70.1-33.67-52.6-46.15-48.54-64.81-35.52-53.53-41.02-14.8311.148.95-8.6846.43-19.91-71.28-15.2113.3-88.78
14.2634.0225.6729.15-0.859.32-0.34-3.3667.3424.4241.114.830.81-8.32-6.220.072.130.380.237.3312.30.2111.432.02
0.940.770.380.120.070.060.050.10.766.737.637.346.886.665.874.43.952.642.681.421.081.031.291.48
24.7918.1541.3617.7945.8137.9645.448.9549.3235.4949.919.0239.8329.7720.326.357.91.5413.2316.5719.3316.827.1122.61
27.488557.3757.6172.7249.2387.0581.1973.24104.99107.94123.1690.6273.1885.6976.0295.6275.85149.65103.71102.7873.07117.59-1.77
-16,303-13,917-22,800-26,160-25,127-39,205-43,837-28,558-53,735-45,751-31,259-23,060-19,487-19,827-22,103-18,425-40,072-20,001-24,733-27,622-50,226-37,358-40,467-34,559
-4.05-19.55-7.17-27.72-27.26-37.53-29.52-55.21-476.45-54.95-69.82-58.76-2.5621.7426.16-18.84-6.7-28.617.04-7.92-27.63-36.09-28.85-22.72
12.26-5.6315.63-1.56-2.131.6714.32-26.65-422.71-9.2-38.56-35.716.9341.5748.26-0.4233.37-8.641.7719.722.61.2711.6211.84
000000000000000000000000
-8.95-11.29-17.01-1.020.070.67-0.51-0.19412.588.99-7.28-24-34-38.41-71.44-17.15-30.329.98-38.61-35.67-57.93-10.04-5.4121.29
70-13,910-9,225-11,400-6,0870-11,0600000000000000000
-15.36-17.71-39.08-19.83-21.36-16.74-21.84-40.62375.37-30.97-49.24-68-77.98-81.81-114.8-59.74-72.94-35.44-81.85-79.18-103.53-55.91-48.97-24.52
-0.05-0.06-0.46-0.3-0.11-0.110.10.54-0.28-1.5-2.07-1.26-1.23-0.64-0.580.220.24-2.52-0.32-0.550.2502.320.08
-6,372-6,373-7,707-9,288-9,920-11,223-21,435-29,913-36,938-38,462-39,887-42,740-42,744-42,748-42,777-42,810-42,865-42,905-42,929-42,957-45,849-45,868-45,878-45,893
5.6353.7815.425.5118.85-3.6940.85-12.19-51.1411.58-16.4-12.339.7729.8911.4619.415.997.4583.7521.4-37.68-5.560.89-42.28
11,18071,07834,57231,44647,58910,02243,21652,62719,50759,23576,684100,09571,13653,35463,58557,59855,54655,851124,91676,09252,55635,70977,122-36,331
000000000000000000000000

Eisai Co stock margins

The Eisai Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eisai Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eisai Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Eisai Co's sales revenue. A higher gross margin percentage indicates that the Eisai Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Eisai Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Eisai Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Eisai Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Eisai Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Eisai Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Eisai Co Margin History

Eisai Co Gross marginEisai Co Profit marginEisai Co EBIT marginEisai Co Profit margin
2027e79.06 %9.89 %8.16 %
2026e79.06 %8.38 %7.09 %
2025e79.06 %7.76 %5.81 %
202479.06 %6.27 %5.72 %
202376.12 %5.43 %7.45 %
202278.1 %7.12 %6.34 %
202175.04 %8.21 %6.49 %
202075.91 %19.58 %17.5 %
201971.34 %14.52 %9.86 %
201866.48 %12.7 %8.64 %
201763.73 %11.28 %7.3 %
201664.6 %10.09 %10.03 %
201564.7 %5.21 %7.89 %
201468.66 %11.84 %5.49 %
201369.65 %12.28 %8.42 %
201273.25 %14.78 %9.03 %
201178.18 %14.71 %8.76 %
201079.99 %10.76 %5.02 %
200980.5 %11.74 %6.1 %
200883.8 %2.42 %-2.32 %
200783.78 %15.62 %10.48 %
200682.54 %15.83 %10.55 %
200581.43 %16.21 %10.41 %

Eisai Co Stock Sales Revenue, EBIT, Earnings per Share

The Eisai Co earnings per share therefore indicates how much revenue Eisai Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eisai Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eisai Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eisai Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eisai Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eisai Co Revenue, EBIT and net profit per share

DateEisai Co Sales per ShareEisai Co EBIT per shareEisai Co Earnings per Share
2027e3,173.7 undefined0 undefined258.96 undefined
2026e2,986.73 undefined0 undefined211.81 undefined
2025e2,709.7 undefined0 undefined157.46 undefined
20242,586.27 undefined162.07 undefined147.86 undefined
20232,595.9 undefined141.03 undefined193.3 undefined
20222,637.42 undefined187.86 undefined167.25 undefined
20212,252.92 undefined184.91 undefined146.29 undefined
20202,426.74 undefined475.25 undefined424.8 undefined
20192,242.47 undefined325.52 undefined221.12 undefined
20182,094.58 undefined265.93 undefined180.97 undefined
20171,882.18 undefined212.3 undefined137.41 undefined
20161,912.69 undefined192.94 undefined191.76 undefined
20151,919.39 undefined100.08 undefined151.37 undefined
20142,106.54 undefined249.49 undefined115.63 undefined
20132,012.84 undefined247.24 undefined169.39 undefined
20122,273.6 undefined335.96 undefined205.3 undefined
20112,697.94 undefined396.9 undefined236.47 undefined
20102,818.08 undefined303.19 undefined141.54 undefined
20092,742.96 undefined322.14 undefined167.29 undefined
20082,585.51 undefined62.52 undefined-59.9 undefined
20072,365.3 undefined369.36 undefined247.77 undefined
20062,102.28 undefined332.72 undefined221.71 undefined
20051,857.18 undefined301.03 undefined193.4 undefined

Eisai Co business model

Eisai Co Ltd is a Japanese pharmaceutical company based in Tokyo that specializes in research, development, production, and marketing of pharmaceuticals. The company was founded in 1936 by Shinjiro Torii, who had previously worked as a chemist at another pharmaceutical company. Eisai began its journey in the production of medicines, especially herbal medicine known in Japan, which are sold as OTC products. Eisai grew rapidly and started producing antibiotics in 1947. Over the following decades, the company expanded into the global market and is now present in over 20 countries. Eisai is dedicated to creating innovations as its main business model in order to help patients worldwide through its range of products. With this mission, the company has developed and introduced hundreds of drugs to the market, improving the quality of life for millions of people around the world. The company is divided into several business segments, including neurology, oncology, coagulation disorders, and gastrointestinal diseases. Eisai specializes in developing innovative drugs targeting a wide range of human diseases. Eisai is particularly known today for its leading position in Alzheimer's and dementia research. An important milestone in the company's history was the discovery of Aricept, a medication used to treat Alzheimer's disease. Eisai was the first Japanese company to develop a drug approved by the US FDA. Other products from Eisai include Lenvima, a medication for the treatment of thyroid cancer, and Lusedra, a sedative for anesthesia induction and maintenance for patients undergoing surgery. Eisai invests significantly in research and development to maintain its position as an innovation leader in the pharmaceutical manufacturing industry. The company collaborates with leading academic institutions and research organizations to make groundbreaking discoveries in various medical fields. Eisai also places importance on social responsibility and is involved in numerous social projects such as supporting Japan against cancer and providing consultation for elderly home care. The company aims to contribute to making the healthcare system more sustainable and equitable. Overall, Eisai is a leading pharmaceutical company with a strong focus on creating innovations to improve human health. It has a wide range of products and continuously works on developing new drugs and therapies to help patients worldwide. Eisai Co is one of the most popular companies on Eulerpool.com.

Eisai Co SWOT Analysis

Strengths

Eisai Co Ltd has a strong global presence and is a leading player in the pharmaceutical industry. They have a diverse portfolio of products and a strong brand reputation. The company has a dedicated research and development team and invests significantly in innovation. They have a robust manufacturing and supply chain network which ensures timely delivery of their products.

Eisai Co Ltd has established strategic partnerships and collaborations with other pharmaceutical companies, enabling them to access new markets and expand their product offerings. They have a strong financial position and a history of consistent revenue growth.

Weaknesses

One of the weaknesses of Eisai Co Ltd is their heavy reliance on a few key products for a significant portion of their revenue. This leaves them vulnerable to market fluctuations and competition. They have a relatively small market share in certain regions, limiting their potential for growth.

The company has faced challenges in ensuring regulatory compliance, which can result in delays in product approvals and launches. They also face risks associated with patent expirations and generic competition.

Opportunities

Eisai Co Ltd has the opportunity to expand their presence in emerging markets where there is a growing demand for healthcare products. They can also explore new therapeutic areas and invest in research and development to develop innovative treatments.

The aging population in many countries presents an opportunity for Eisai Co Ltd to develop and market products catering to the specific needs of older adults. They can also focus on developing personalized medicine and digital healthcare solutions.

Threats

Eisai Co Ltd faces intense competition from other pharmaceutical companies, including both established players and emerging biotech firms. The ever-changing regulatory environment and increasing scrutiny on pricing and reimbursement pose challenges to their business.

The company is also exposed to risks associated with potential adverse effects of their products, which could lead to lawsuits and reputational damage. Changes in healthcare policies and the potential impact of global economic uncertainties are additional threats they need to consider.

Eisai Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Eisai Co historical P/E ratio, EBIT, and P/S ratio.

Eisai Co shares outstanding

The number of shares was Eisai Co in 2023 — This indicates how many shares 286.761 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eisai Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eisai Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eisai Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eisai Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eisai Co Stock splits

In Eisai Co's history, there have been no stock splits.

Eisai Co dividend history and estimates

In 2023, Eisai Co paid a dividend amounting to 160 JPY. Dividend means that Eisai Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Eisai Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Eisai Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Eisai Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Eisai Co Dividend History

DateEisai Co Dividend
2027e160.86 undefined
2026e161.13 undefined
2025e160.96 undefined
2024160 undefined
2023160 undefined
2022160 undefined
2021160 undefined
2020160 undefined
2019160 undefined
2018150 undefined
2017150 undefined
2016150 undefined
2015150 undefined
2014150 undefined
2013150 undefined
2012150 undefined
2011150 undefined
2010150 undefined
2009140 undefined
2008135 undefined
2007130 undefined
2006145 undefined
200575 undefined

Eisai Co dividend payout ratio

In 2023, Eisai Co had a payout ratio of 80.9%. The payout ratio indicates the percentage of the company's profits that Eisai Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Eisai Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Eisai Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Eisai Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Eisai Co Payout Ratio History

DateEisai Co Payout ratio
2027e91.63 %
2026e88.95 %
2025e90.63 %
202495.32 %
202380.9 %
202295.67 %
2021109.38 %
202037.67 %
201972.36 %
201882.89 %
2017109.16 %
201678.22 %
201599.09 %
2014129.72 %
201388.56 %
201273.06 %
201163.43 %
2010105.98 %
200983.68 %
2008-225.38 %
200752.47 %
200665.4 %
200538.78 %
Unfortunately, there are currently no price targets and forecasts available for Eisai Co.

Eisai Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/202424.71 36.95  (49.55 %)2025 Q1
3/31/202441.51 46.4  (11.78 %)2024 Q4
12/31/202327.6 20.82  (-24.56 %)2024 Q3
9/30/202326.86 9.72  (-63.81 %)2024 Q2
6/30/202321.16 70.92  (235.18 %)2024 Q1
3/31/202381.26 56.92  (-29.96 %)2023 Q4
12/31/202230.06 30.14  (0.27 %)2023 Q3
9/30/202227.38 12.44  (-54.57 %)2023 Q2
6/30/202235.54 93.81  (163.97 %)2023 Q1
3/31/2022-15.63 -43.27  (-176.88 %)2022 Q4
1
2
3
4
5
...
7

Eulerpool ESG Scorecard© for the Eisai Co stock

Eulerpool World ESG Rating (EESG©)

92/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

79

Environment

Scope 1 - Direct Emissions
47,507
Scope 2 - Indirect emissions from purchased energy
6,105
Scope 3 - Indirect emissions within the value chain
602,655
Total CO₂ emissions
53,612
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees42
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Eisai Co list of shareholders

%
Name
Stocks
Change
Date
7.12558 % Wellington Management Company, LLP20,361,555-6,6702/29/2024
5.93032 % Nomura Asset Management Co., Ltd.16,946,082-75,4003/31/2024
2.95094 % Nikko Asset Management Co., Ltd.8,432,400284,9749/29/2023
2.89174 % Mitsubishi UFJ Trust and Banking Corporation8,263,2468,263,24610/31/2022
2.79072 % Daiwa Asset Management Co., Ltd.7,974,557-26,6433/31/2024
2.77183 % Sumitomo Mitsui Trust Asset Management Co., Ltd.7,920,6007,837,2269/29/2023
2.66919 % The Vanguard Group, Inc.7,627,29980,4003/31/2024
2.47446 % BlackRock Institutional Trust Company, N.A.7,070,84968,4003/31/2024
2.27469 % Nippon Life Insurance Company6,500,000-2,097,0009/30/2023
1.67977 % Saitama Resona Bank, Ltd.4,800,000-500,0009/30/2023
1
2
3
4
5
...
10

Eisai Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Sysmex Stock
Sysmex
SupplierCustomer0,840,530,730,940,540,17
Ajinomoto Stock
Ajinomoto
SupplierCustomer0,660,550,760,51-0,58-0,41
Kissei Pharmaceutical Stock
Kissei Pharmaceutical
SupplierCustomer0,640,480,10-0,77-0,46-0,19
Ligand Pharmaceuticals Stock
Ligand Pharmaceuticals
SupplierCustomer0,610,560,670,900,36-0,01
FUJIFILM Holdings Stock
FUJIFILM Holdings
SupplierCustomer0,590,710,760,940,45-0,13
Omnicom Stock
Omnicom
SupplierCustomer0,570,560,46-0,56-0,34-0,47
House of Investments Stock
House of Investments
SupplierCustomer0,460,530,210,79-0,13-0,41
Soho Global Health Stock
Soho Global Health
SupplierCustomer0,450,480,450,200,640,01
State Street Stock
State Street
SupplierCustomer0,440,520,550,580,10-0,26
Xi'an Manareco New Materials A Stock
Xi'an Manareco New Materials A
SupplierCustomer0,40-0,28-0,020,35-0,20-
1
2
3
4
5
...
6

Most common questions regarding Eisai Co

What values and corporate philosophy does Eisai Co represent?

Eisai Co Ltd represents a set of core values and a corporate philosophy that guides its operations. The company is committed to human health care and believes in "human health care" (hhc) as an essential principle. Eisai aims to contribute to the well-being of patients through innovative pharmaceuticals and healthcare services. The company emphasizes the importance of gaining trust from patients, healthcare professionals, and the global community while striving for continuous improvement. Eisai Co Ltd focuses on creating value for patients and society, matching scientific competence with a compassionate approach. Emphasizing patient-centricity, Eisai Co Ltd constantly endeavors to fulfill its mission of providing effective treatments and improving the quality of life for patients worldwide.

In which countries and regions is Eisai Co primarily present?

Eisai Co Ltd is primarily present in various countries and regions across the globe. The company has significant presence in its home country, Japan, where it is headquartered. Furthermore, Eisai Co Ltd has expanded its operations to the United States, Europe, Asia, and other key markets. With its strong focus on global growth, Eisai Co Ltd has established subsidiaries and affiliates in multiple countries, enabling it to reach a wider customer base and cater to diverse markets.

What significant milestones has the company Eisai Co achieved?

Eisai Co Ltd, a renowned pharmaceutical company, has achieved notable milestones throughout its history. The company successfully developed and introduced innovative healthcare solutions, contributing to advancements in medicine. Eisai Co Ltd made significant strides in the discovery and development of drugs for various therapeutic areas, including oncology, neurology, and gastrointestinal disorders. It received numerous regulatory approvals for its groundbreaking medications, enhancing patient care worldwide. Eisai Co Ltd's relentless commitment to research and development has resulted in the introduction of groundbreaking treatments, earning recognition and trust from both healthcare professionals and patients alike.

What is the history and background of the company Eisai Co?

Eisai Co Ltd is a renowned pharmaceutical company founded in 1941 in Japan. With a rich history spanning over 80 years, Eisai has established itself as a global leader in the healthcare industry. The company focuses on discovering, developing, and marketing innovative medications to address various medical needs. Eisai is committed to improving the lives of patients worldwide and has made significant contributions to research and development in the areas of neurology, oncology, and gastrointestinal disorders. Known for its dedication to patient-centered care, Eisai continues to make strides in advancing medical science and delivering effective therapeutic solutions to support human health.

Who are the main competitors of Eisai Co in the market?

Some of the main competitors of Eisai Co Ltd in the market include pharmaceutical companies such as Pfizer, Roche, Novartis, and Gilead Sciences.

In which industries is Eisai Co primarily active?

Eisai Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Eisai Co?

The business model of Eisai Co Ltd involves being a global pharmaceutical company focused on the discovery, development, and marketing of innovative medicines. Eisai Co Ltd aims to address unmet medical needs in areas such as neurology and oncology, along with supportive care. With a patient-centered approach, the company combines its expertise in research and development with strategic partnerships to deliver solutions for improved healthcare outcomes. Eisai Co Ltd emphasizes creating sustainable value and contributing to society through its pharmaceutical products and services.

What is the P/E ratio of Eisai Co 2024?

The Eisai Co P/E ratio is 39.23.

What is the P/S ratio of Eisai Co 2024?

The Eisai Co P/S ratio is 2.24.

What is the AlleAktien quality score of Eisai Co?

The AlleAktien quality score for Eisai Co is 2/10.

What is the revenue of Eisai Co 2024?

The Eisai Co revenue is 741.75 B JPY.

How high is the profit of Eisai Co 2024?

The Eisai Co profit is 42.41 B JPY.

What is the business model of Eisai Co

Eisai Co Ltd is a company specializing in the research, development, production, and marketing of pharmaceuticals and preparations. The Japanese company was founded in 1949 and is headquartered in Tokyo. The company is divided into several business divisions to manage its product lines. The "Neurology" division specializes in the treatment of Alzheimer's, Parkinson's, and epilepsy, offering a wide range of medications for these diseases. Eisai's "Oncology" division focuses on developing drugs for the treatment of cancer. The company works to develop innovative therapies that improve the quality of life and cure cancer patients. Products in this area include Lenvima, Halaven, and Kisplyx. Eisai's "Gastroenterology" division offers drugs for the treatment of gastrointestinal disorders, including functional dyspepsia, reflux esophagitis, enteritis, colitis, and stool regulation. This includes drugs such as Aciphex and Targaxan. Another business division of Eisai is the "Integumentary System," which focuses on products for the treatment of skin diseases such as psoriasis, acne, and atopic dermatitis. This includes products like Tazorac and Erivedge. In addition, Eisai operates its own research and development department to bring innovative drugs to the market. The company collaborates with scientific and medical partners worldwide and continuously invests in the research and development of new drugs. Furthermore, in recent years, the company has expanded its presence in the Asia-Pacific region and North America. Eisai also has joint ventures and partnerships with other companies to bring innovative products to the market, optimizing product development, production, and marketing. An example of this is the collaboration with Biogen for the development and marketing of therapies for Alzheimer's disease. Overall, Eisai specializes in providing innovative and high-quality pharmaceuticals and therapies to improve the lives of patients worldwide. The company is dedicated to research and development of new products and has a wide range of business divisions and partnerships to expand its portfolio and global presence.

What is the Eisai Co dividend?

Eisai Co pays a dividend of 160 JPY distributed over 2 payouts per year.

How often does Eisai Co pay dividends?

Eisai Co pays out a dividend 2 times a year.

What is the Eisai Co ISIN?

The ISIN of Eisai Co is JP3160400002.

What is the Eisai Co WKN?

The WKN of Eisai Co is 855526.

What is the Eisai Co ticker?

The ticker of Eisai Co is 4523.T.

How much dividend does Eisai Co pay?

Over the past 12 months, Eisai Co paid a dividend of 160 JPY . This corresponds to a dividend yield of about 2.76 %. For the coming 12 months, Eisai Co is expected to pay a dividend of 160.96 JPY.

What is the dividend yield of Eisai Co?

The current dividend yield of Eisai Co is 2.76 %.

When does Eisai Co pay dividends?

Eisai Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Eisai Co?

Eisai Co paid dividends every year for the past 23 years.

What is the dividend of Eisai Co?

For the upcoming 12 months, dividends amounting to 160.96 JPY are expected. This corresponds to a dividend yield of 2.78 %.

In which sector is Eisai Co located?

Eisai Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eisai Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eisai Co from 12/1/2024 amounting to 80 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Eisai Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Eisai Co in the year 2023?

In the year 2023, Eisai Co distributed 160 JPY as dividends.

In which currency does Eisai Co pay out the dividend?

The dividends of Eisai Co are distributed in JPY.

All fundamentals about Eisai Co

Our stock analysis for Eisai Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eisai Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.